BW Communities

Articles for Healthcare

Ayurveda Is About Proactive, Holistic Health: Ameve Sharma, Co-Founder, Kapiva

Backed by the iconic Baidyanath Group, Kapiva, a functional foods brand focused on bringing selectively sourced Ayurveda-inspired, natural foods to consumers. Ameve Sharma, Co-founder Kapiva talks to ASHISH SINHA of BW Businessworld on impact of Covid on Ayurveda, its growing popularity and its expansion plans. Excerpts:

Read More
Heyday joins hands with Okhai to provide natural feminine care to tribal artisans

The initiative called #WeAreEqual, urges all men and women to participate in raising awareness towards women's equality in India.

Read More
Prescriptions for E-Pharmacy

De-coupling legality from sectoral hygiene can provide necessary certainty to entrepreneurs to invest and take risks. It also reduces the need for judicial intervention that can stymie new markets.

Read More
Zydus Cadila Gets Tentative USFDA Nod To Market Anti-cancer Drug

The company said the newly approved medication will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.

Read More
Gilead To Pay $97 Million To Settle U.S. Kickback Probe

Gilead's actions enabled the Foster City, California-based drugmaker to boost revenue, ran from June 2007 to December 2010, and violated the federal False Claims Act, the department said.

Read More
Industry Says $6 To $18 Per Dose Is Reasonable Price For COVID-19 Vaccine

A price between 5 and 15 euros a dose "is a reasonable price for a vaccine," Sue Middleton, President of the Executive Board, of Vaccines Europe told a hearing in the EU Parliament.

Read More
India Trials For Russia's 'Sputnik-V' Vaccine Could Start In Next Few Weeks - Executive

India, which has a population of more than 1.3 billion, is the world's second worst affected country by COVID-19 behind the United States.

Read More
Prescriptions For E-Pharmacy

Legal uncertainty is detrimental to market and consumer interests because it encourages new entrants to grow in a manner that they become ‘too big to regulate’.

Read More

Subscribe to our newsletter to get updates on our latest news